AI
BIIB icon

Axiom Investors’s Biogen BIIB Stock Holding History

Axiom Investors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-55,672
Closed -$16.8M – 125
2018
Q4 		$16.8M Hold
55,672
– – 0.58% 44
2018
Q3 		$19.7M Sell
55,672
-73
-0.1% -$25.1K 0.56% 48
2018
Q2 		$16.2M Sell
55,745
-29,515
-35% -$8.3M 0.49% 50
2018
Q1 		$23.3M Sell
85,260
-170
-0.2% -$52.8K 0.57% 51
2017
Q4 		$27.2M Buy
+85,430
New +$27.4M 0.68% 45
2015
Q4 		– Sell
-103,352
Closed -$30.2M – 133
2015
Q3 		$30.2M Buy
103,352
+2,076
+2% +$686K 0.95% 43
2015
Q2 		$40.9M Sell
101,276
-82,728
-45% -$33.2M 1.17% 38
2015
Q1 		$77.7M Buy
184,004
+69,804
+61% +$27.5M 2.1% 13
2014
Q4 		$38.8M Buy
+114,200
New +$36.9M 0.96% 44

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axiom Investors's BIIB Position: Q1 2019 in Review

Axiom Investors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 55,672 shares — an estimated $16.8M sold.

Axiom Investors first reported a position in BIIB in Q4 2014 and held it in 9 quarters. The position peaked at $77.7M in Q1 2015. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Axiom Investors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Axiom Investors sold 55,672 Biogen shares in Q1 2019, an estimated $16.8M.
  • Axiom Investors first reported a position in Biogen in Q4 2014 and held it in 9 quarters.
  • Axiom Investors's Biogen position peaked at $77.7M in Q1 2015.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Axiom Investors's 13F filing for Q1 2019, filed 13 May 2019.